Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome
Background Insulin-like growth factor-binding protein (IGFBP) 2 plays an important role in the regulation of cell adhesion, migration, growth, and apoptosis. This study aimed to investigate the clinical significance of serum IGFBP2 as a biomarker for disease activity and severity in hemolytic uremic...
Main Authors: | Yuko Tasaki, Natsumi Inoue, Masaki Shimizu, Naotoshi Sugimoto, Sayaka Ishikawa, Mao Mizuta, Tadafumi Yokoyama, Mondo Kuroda, Kazuhide Ohta, Akihiro Yachie, Taizo Wada |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0886022X.2021.1885445 |
Similar Items
-
Hemolytic uremic syndrome – emergency in an infant
by: Jana Jelčić, et al.
Published: (2023-01-01) -
Adult hemolytic uremic syndrome
by: Micaela Viciconte, et al.
Published: (2023-03-01) -
Hepatitis B Vaccine-Associated Atypical Hemolytic Uremic Syndrome
by: Zekai Avcı, et al.
Published: (2013-12-01) -
Atypical hemolytic uremic syndrome: a brief review
by: Kuixing Zhang, et al.
Published: (2017-06-01) -
Hemolytic Uremic Syndrome; 10 Year Single Center Experience
by: Sibel YEL, et al.
Published: (2022-04-01)